Pioneer of Abortion Pill, Dr. Étienne-Émile Baulieu, Passes Away at 98

Dr. Étienne-Émile Baulieu, the French scientist who developed the abortion pill RU-486, has died at age 98. Known for his commitment to women's freedom and scientific advancement, Baulieu's work has transformed reproductive rights globally. His contributions faced significant opposition, yet he persistently advocated for the drug's approval, emphasizing human dignity throughout his life.

Dr. Étienne-Émile Baulieu, the visionary French scientist who played a crucial role in the development of the abortion pill, mifepristone (RU-486), has passed away at the age of 98. He died in his Paris home, as confirmed by his widow, Simone Harari Baulieu. She remarked on his unwavering commitment to advancing science and enhancing women's freedoms through his research.

In a tribute, French President Emmanuel Macron heralded Dr. Baulieu as a "beacon of courage," emphasizing the immense impact he had in changing the world for women. Gender equality minister Aurore Bergé acknowledged that his life's work was always aligned with upholding human dignity.

Dr. Baulieu, originally named Étienne Blum, was born in Strasbourg on December 12, 1926. He joined the French resistance against Nazi occupation at the tender age of 15, later adopting his alias to further his cause. His academic journey took him to the United States, where he collaborated with Dr. Gregory Pincus, a pioneer of the contraceptive pill.

After returning to France, Baulieu devised a method to obstruct the function of progesterone, a hormone vital for pregnancy. Although he developed the abortion pill within a decade, he faced significant resistance and threats as he lobbied for its approval, which was finally granted in 1988, igniting controversy across both Europe and the United States.

Despite mifepristone being accepted in over 100 nations, access remains limited in several regions, including various states in the US. Critics have disseminated misleading claims regarding the pill's safety, even though medical authorities affirm its reliability. The World Health Organization recognized mifepristone as an essential medication in 2010, highlighting its importance in reproductive health.

In recent years, Baulieu continued to advocate for women's rights, expressing his dismay over increasing restrictions on abortion access. He also focused on researching treatments for Alzheimer's disease and severe depression.

In a fitting recognition of his contributions, Macron awarded Baulieu the Grand Cross of the Legion d'Honneur in 2023, underscoring his dedication to freedom and scientific inquiry despite facing hostility throughout his career.